Literature DB >> 22334175

A possible link of oxaliplatin-induced neuropathy with potassium channel deficit.

Alexander G Dimitrov1, Nonna A Dimitrova.   

Abstract

INTRODUCTION: The neurotoxic side effects of oxaliplatin (a reference drug in the treatment of digestive tract tumors) can force suspension of treatment. The mechanisms of neuropathy are unclear. We aimed to simulate oxaliplatin-induced hyperactivity in myelinated axons (MA) based on published experimental data.
METHODS: A Hodgkin-Huxley-type multi-cable MA model was used, which took into account active internodal processes and accumulation of ions in MA with 21 nodes.
RESULTS: Even a very short (110-220 μm) internodal region devoid of potassium channels was sufficient to produce after-discharges in response to a saltatory action potential. An increase in the density of sodium channels, slowdown of their inactivation, and negative shifts along one node-internode region of the voltage dependence of sodium and potassium activation and of sodium inactivation induced no after-discharge.
CONCLUSION: A combination of sodium channel blockers with drugs that obstruct the blockage of potassium channels or contribute to their opening could be effective in preventing oxaliplatin-induced "hyperexcitability."
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334175     DOI: 10.1002/mus.22311

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

Review 1.  Emerging trends in understanding chemotherapy-induced peripheral neuropathy.

Authors:  Jérémy Ferrier; Vanessa Pereira; Jérome Busserolles; Nicolas Authier; David Balayssac
Journal:  Curr Pain Headache Rep       Date:  2013-10

2.  Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.

Authors:  Romain Coriat; Jérôme Alexandre; Carole Nicco; Laurent Quinquis; Evelyne Benoit; Christiane Chéreau; Hervé Lemaréchal; Olivier Mir; Didier Borderie; Jean-Marc Tréluyer; Bernard Weill; Joel Coste; François Goldwasser; Frédéric Batteux
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

Review 3.  Mechanisms involved in the development of chemotherapy-induced neuropathy.

Authors:  Jessica A Boyette-Davis; Edgar T Walters; Patrick M Dougherty
Journal:  Pain Manag       Date:  2015-06-19

Review 4.  Mechanisms of distal axonal degeneration in peripheral neuropathies.

Authors:  Christopher R Cashman; Ahmet Höke
Journal:  Neurosci Lett       Date:  2015-01-21       Impact factor: 3.046

5.  Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?

Authors:  Elisa Ballarini; Alessio Malacrida; Virginia Rodriguez-Menendez; Eleonora Pozzi; Annalisa Canta; Alessia Chiorazzi; Laura Monza; Sara Semperboni; Cristina Meregalli; Valentina Alda Carozzi; Maryamsadat Hashemi; Gabriella Nicolini; Arianna Scuteri; Stephen N Housley; Guido Cavaletti; Paola Alberti
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.